Literature DB >> 10863626

Fetal macrosomia: etiologic factors.

O Langer1.   

Abstract

Fetal growth can be considered the outcome of an interaction between the genetic cause of growth and constraints provided by limitations on substrate availability (selected amino acids, free fatty acids, and mainly glucose). It should be noted that the majority of large infants are constitutionally large and do not require special intervention, which will result in adverse perinatal outcome. Efforts should be directed to the accelerated (pathologic) overgrown fetus and to methods of primary prevention of this abnormality by appropriate management approaches for the mother and fetus.

Entities:  

Mesh:

Year:  2000        PMID: 10863626     DOI: 10.1097/00003081-200006000-00006

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  27 in total

1.  Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria.

Authors:  E P O'Sullivan; G Avalos; M O'Reilly; M C Dennedy; G Gaffney; F Dunne
Journal:  Diabetologia       Date:  2011-04-15       Impact factor: 10.122

2.  Effects of prenatal exposure to ambient air pollutant PM10 on ultrasound-measured fetal growth.

Authors:  Nan Zhao; Jie Qiu; Shuangge Ma; Yaqun Zhang; Xiaojuan Lin; Zhongfeng Tang; Honghong Zhang; Huang Huang; Ning Ma; Yuan Huang; Michelle L Bell; Qing Liu; Yawei Zhang
Journal:  Int J Epidemiol       Date:  2018-08-01       Impact factor: 7.196

3.  Being macrosomic at birth is an independent predictor of overweight in children: results from the IDEFICS study.

Authors:  Sonia Sparano; Wolfgang Ahrens; Stefaan De Henauw; Staffan Marild; Denes Molnar; Luis A Moreno; Marc Suling; Michael Tornaritis; Toomas Veidebaum; Alfonso Siani; Paola Russo
Journal:  Matern Child Health J       Date:  2013-10

4.  Growth factors, adiponectin, leptin and body mass index in pre-pubertal children born large for gestational age.

Authors:  A S Challa; E N Evagelidou; V I Giapros; V I Cholevas; S K Andronikou
Journal:  J Endocrinol Invest       Date:  2010-06-28       Impact factor: 4.256

5.  Enhanced fasting glucose turnover in mice with disrupted action of TUG protein in skeletal muscle.

Authors:  Michael G Löffler; Andreas L Birkenfeld; Katerina M Philbrick; Jonathan P Belman; Estifanos N Habtemichael; Carmen J Booth; Carlos M Castorena; Cheol Soo Choi; Francois R Jornayvaz; Brandon M Gassaway; Hui-Young Lee; Gregory D Cartee; William Philbrick; Gerald I Shulman; Varman T Samuel; Jonathan S Bogan
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

Review 6.  Maternal obesity and fetal metabolic programming: a fertile epigenetic soil.

Authors:  Margaret J R Heerwagen; Melissa R Miller; Linda A Barbour; Jacob E Friedman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-07-14       Impact factor: 3.619

7.  Biological indicators of the in-utero environment and their association with birth weight for gestational age.

Authors:  N M Talge; C Holzman; P K Senagore; M Klebanoff; R Fisher
Journal:  J Dev Orig Health Dis       Date:  2011-10       Impact factor: 2.401

8.  Racial and Ethnic Patterning of Low Birth Weight, Normal Birth Weight, and Macrosomia.

Authors:  Annie Ro; Rachel E Goldberg; Jennifer B Kane
Journal:  Prev Med       Date:  2018-10-18       Impact factor: 4.018

9.  Factors associated with small- and large-for-gestational-age in socioeconomically vulnerable individuals in the 100 Million Brazilian Cohort.

Authors:  Ila R Falcão; Rita de Cássia Ribeiro-Silva; Marcia Furquim de Almeida; Rosemeire L Fiaccone; Natanael J Silva; Enny S Paixao; Maria Yury Ichihara; Laura C Rodrigues; Mauricio L Barreto
Journal:  Am J Clin Nutr       Date:  2021-07-01       Impact factor: 7.045

10.  Maternal glycemia and risk of large-for-gestational-age babies in a population-based screening.

Authors:  Zsuzsa Kerényi; Gyula Tamás; Mika Kivimäki; Andrea Péterfalvi; Eszter Madarász; Zsolt Bosnyák; Adam G Tabák
Journal:  Diabetes Care       Date:  2009-09-03       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.